|
FY2023
12 months to Feb 29, 2024
|
|
|---|---|
| Loss for the year | |
| Non-cash expense: | |
| Share based compensation | |
| Financing fee | |
| Gain on amortization of flow-through share premium liability | |
| Impairment of mineral properties | |
| Foreign exchange gain on investments | |
| Gain on investments measured at fair value through profit or loss | |
| Amounts receivable | |
| Prepaid expenses | |
| Accounts payable and accrued liabilities | |
| Restricted cash | |
| Net cash used in Operating Activities | |
| Financing Activities | |
| Issuance of shares and warrants | |
| Share issue costs | |
| Issuance of shares via exercise of options and warrants | |
| Net cash provided by Financing Activities | |
| Net change in cash for the year | |
| Cash and cash equivalents, beginning of the year | |
| Cash and cash equivalents, end of the year | |
| Recognition of flow-through liability | |
| Purchase of exploration and evaluation assets by issue of shares | |
| Deferred loan commitment fee | |
| Shares and warrants issued for broker fees | |
| Transfer of contributed surplus upon warrant exercise | |
| Shares issued upon exercise of RSUs | |
| Shares issued for settlement of debt | |
| Shares issued for settlement of accounts payable |
Loading...
